Blogs

1. A Bright Future For Eye Care: The Advanced Therapy Revolution Is Here 4/10/2025

   Groundbreaking cell and gene therapies are revolutionizing eye care. Discover how advanced treatments target root causes, offering unprecedented hope for conditions previously deemed untreatable.

2. Navigating Patient Access Challenges In Commercializing Your CGT Product 3/10/2025

   Learn how to effectively break down barriers to patient access in cell and gene therapy by enhancing provider education, streamlining coordination, and expanding patient support.

3. Expanding Patient Access To Cell And Gene Therapies: Optimizing Channel Strategy 1/31/2025

   Rare disease innovation demands robust channel strategies for patient access. Learn how a patient-centric approach, logistical solutions, and strong partnerships are key to successful patient access.

4. Navigating The CGT Landscape: Key Takeaways From The FDA's New FAQ 1/6/2025

   The FDA's new FAQ on cell and gene therapy offers a roadmap for developers. Review key insights from the document, including the importance of early engagement with the FDA, CMC considerations, and more.

5. Unraveling The Complexity Of Cell Therapy: Advancements And Challenges 11/26/2024

   Cell therapy has emerged as a powerful tool for addressing critical medical challenges, but its rapid evolution necessitates a clear regulatory framework and consistent terminology.

6. Expert Insights In Navigating CGT's Complex Supply Chain 10/30/2024

   Examine insights shared during Cencora's ThinkLive Cell and Gene Therapy Summit 2024 that shed light on the challenges and opportunities in navigating the complexities of the cell and gene supply chain.

7. The Unique Challenges Of The Cell & Gene Therapy Supply Chain 10/28/2024

   Cell and gene therapies present unique logistical challenges for the supply chain, requiring careful consideration of factors like shelf life, packaging, temperature, and chain of custody.

8. Navigating The Cell And Gene Regulatory Landscape 10/3/2024

   Navigating the complex regulatory landscape is essential for cell and gene therapy success. Explore key considerations, challenges, and best practices for companies operating in this space.

9. Key Takeaways And Market Insights From The Inaugural ThinkLive Summit 8/30/2024

   The inaugural ThinkLive Cell and Gene Therapy Summit explored the industry’s dynamic landscape, highlighting collaboration, communication, and market access challenges.

10. How Patient-Centric Approaches Are Shaping The Future Of CGT 8/6/2024

    Emily Whitehead’s CAR-T cell therapy journey highlights the power of patient engagement in cell and gene therapies. Discover how her story and advocacy drive a patient-centric approach in innovative treatments.